What is AngioDynamics's stock issuance proceeds?

AngioDynamics (ANGO) reported stock issuance proceeds of $716K in Q4 2025.

How has AngioDynamics's stock issuance proceeds changed year-over-year?

AngioDynamics's stock issuance proceeds decreased by 20.0% year-over-year, from $895K to $716K.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

AngioDynamics ANGO Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

AbbottABT

$116M-59.6%

Merit Medical SystemsMMSI

$2.78M-78.9%

ICU MedicalICUI

$0-100%

PenumbraPEN

$0-100%

MedtronicMDT

$97M-10.2%

ArtivionAORT

$1.25M-70.1%

Other financials

Income statement

See full

Revenue$78.4M+8.9%

Gross profit$41.5M+6.7%

Operating income-$13.0M-29.8%

Net income-$8.1M-83.4%

EPS (diluted)-$0.19-72.7%

Balance sheet

See full

Cash & equivalents$37.8M-15.5%

Total debt$7.9M+10.2%

Total equity$173.4M-6.7%

Total assets$260.7M-8.7%

Cash flow

See full

Operating cash flow-$3.1M+76.4%

CapEx$1.0M-43.5%

Free cash flow-$4.1M+72.4%

Valuation

See full

Market cap$564.42M+38.7%

Enterprise value$534.51M+48.0%

P/S1.8×+0.4×

Profitability

See full

Gross margin54.3%-0.1pp

Operating margin-11.3%-2.9pp

Net margin-10%-2.4pp

FCF margin5.5%—

Returns & leverage

See full

Return on equity-17.5%-2.2pp

Debt / equity0×0.0×

Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AngioDynamics's stock issuance proceeds?: AngioDynamics (ANGO) reported stock issuance proceeds of $716K in Q4 2025.
How has AngioDynamics's stock issuance proceeds changed year-over-year?: AngioDynamics's stock issuance proceeds decreased by 20.0% year-over-year, from $895K to $716K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.